Use of maropitant for pain management in domestic rabbits (Oryctolagus cuniculus) undergoing elective orchiectomy or ovariohysterectomy

[1]  L. Benato,et al.  Bristol Rabbit Pain Scale (BRPS): clinical utility, validity and reliability , 2022, BMC Veterinary Research.

[2]  J. Detilleux,et al.  Effects of a Single Opioid Dose on Gastrointestinal Motility in Rabbits (Oryctolagus cuniculus): Comparisons among Morphine, Butorphanol, and Tramadol , 2022, Veterinary sciences.

[3]  D. Gustafson,et al.  Pilot pharmacokinetics of a higher dose of subcutaneous maropitant administration in healthy domestic rabbits (Oryctolagus cuniculus) , 2021, Journal of Exotic Pet Medicine.

[4]  N. Rooney,et al.  Development of the Bristol Rabbit Pain Scale (BRPS): A multidimensional composite pain scale specific to rabbits (Oryctolagus cuniculus) , 2021, PloS one.

[5]  Bhupinder Singh,et al.  Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits. , 2021, Journal of the American Association for Laboratory Animal Science : JAALAS.

[6]  K. Baker,et al.  A Comparison of Buprenorphine, Sustained‑release Buprenorphine, and High-concentration Buprenorphine in Male New Zealand White Rabbits. , 2020, Journal of the American Association for Laboratory Animal Science : JAALAS.

[7]  A. Ricci,et al.  Reliability and construct validity of a composite pain scale for rabbit (CANCRS) in a clinical environment , 2020, PloS one.

[8]  P. Kass,et al.  Pharmacokinetics of maropitant citrate in New Zealand White rabbits (Oryctolagus cuniculus). , 2019, American journal of veterinary research.

[9]  Meloxicam , 2018, Reactions Weekly.

[10]  H. Beaufrère,et al.  Effects of intravenous administration of lidocaine and buprenorphine on gastrointestinal tract motility and signs of pain in New Zealand White rabbits after ovariohysterectomy. , 2017, American journal of veterinary research.

[11]  A. Dugdale,et al.  The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial. , 2017, Veterinary anaesthesia and analgesia.

[12]  Bhupinder Singh,et al.  Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits. , 2017, Journal of the American Association for Laboratory Animal Science : JAALAS.

[13]  K. Yamashita,et al.  Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs , 2017, The Journal of veterinary medical science.

[14]  P. Boscan,et al.  Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy , 2015, PloS one.

[15]  P. Gascón,et al.  Biological and Pharmacological Aspects of the NK1-Receptor , 2015, BioMed research international.

[16]  I. A. Gomez de Segura,et al.  Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: A randomised laboratory study , 2015, European journal of anaesthesiology.

[17]  J. Eickhoff,et al.  Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats. , 2013, Veterinary anaesthesia and analgesia.

[18]  P. Flecknell,et al.  Evaluation of EMLA Cream for Preventing Pain during Tattooing of Rabbits: Changes in Physiological, Behavioural and Facial Expression Responses , 2012, PloS one.

[19]  K. Mama,et al.  Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs. , 2012, Veterinary anaesthesia and analgesia.

[20]  G. Beauchamp,et al.  Evaluation of a fracture pain model in domestic pigeons (Columba livia). , 2012, American journal of veterinary research.

[21]  K. Mama,et al.  Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. , 2011, American journal of veterinary research.

[22]  P. Flecknell,et al.  Are We Looking in the Wrong Place? Implications for Behavioural-Based Pain Assessment in Rabbits (Oryctolagus cuniculi) and Beyond? , 2011, PloS one.

[23]  D. Linder,et al.  A model for clinical evaluation of perioperative analgesia in rabbits (Oryctolagus cuniculus). , 2010, Journal of the American Association for Laboratory Animal Science : JAALAS.

[24]  J. Roughan,et al.  Behavioural effects of ovariohysterectomy and oral administration of meloxicam in laboratory housed rabbits. , 2009, Research in veterinary science.

[25]  D. Scorpio,et al.  Comparison of side effects between buprenorphine and meloxicam used postoperatively in Dutch belted rabbits (Oryctolagus cuniculus). , 2009, Journal of the American Association for Laboratory Animal Science : JAALAS.

[26]  J. Boucher,et al.  The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. , 2007, Journal of veterinary pharmacology and therapeutics.

[27]  F. Shanahan,et al.  The role of substance P in inflammatory disease , 2004, Journal of cellular physiology.

[28]  S. Robertson,et al.  Veterinary anesthesia and analgesia , 2015 .